glp-1 heart palpitations Agonists and Rate: Prevalence and Clinical Significance GLP-1RA in Different HFpEF Phenotypes

Clinical trials of FDA-approved tirzepatide products have shown weight-related effects in some participants when used alongside diet and lifestyle changes

The GLP-1 Analogues Market estimated size and share is projected to exceed USD 322.85 Billion by 2034, with a forecasted CAGR of 21.3% during the period.

Over 18 months, the condition occurred in approximately 8 cases per 10,000 GLP-1 users, compared with 4 to 6 cases among comparison groups

From nausea and exhaustion to emotional shifts and social awkwardness, people on GLP-1 medications are sharing the side effects they didn't expect and rarely see talked about.

In the secondary prevention population, the ICERs were AU$8878 for SGLT2is and AU$79,742 for GLP-1 RAs